Literature DB >> 23845678

Not your usual diarrhoea: severe colonic toxicity of mycophenolate due to intestinal CMV and EBV infection.

Heike Seifert1, Christoph Hess, Luici Terracciano, Jens Eckstein.   

Abstract

We report a case of a 52-year-old woman, on immunosuppressive treatment with mycophenolate due to a history of giant cell myocarditis (GCM), who presented with new-onset severe blood-tinged diarrhoea after a cytomegalovirus (CMV) primoinfection. An extensively prolonged mycophenolate-related colitis was seen after withdrawal of mycophenolate due to an intestinal Epstein-Barr virus (EBV) infection-a rarely seen event itself. We postulate that colonic toxicity was triggered by CMV infection and perpetuated by intestinal EBV replication/infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23845678      PMCID: PMC3736187          DOI: 10.1136/bcr-2013-009882

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Epstein-Barr virus infection of the colon with inflammatory bowel disease.

Authors:  H Yanai; N Shimizu; S Nagasaki; N Mitani; K Okita
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

2.  Rapid resolution of persistent mycophenolate mofetil-induced diarrhoea with a single dose of infliximab.

Authors:  Souad Bouhbouh; Maarten B Rookmaaker
Journal:  Nephrol Dial Transplant       Date:  2010-07-07       Impact factor: 5.992

3.  Patterns of injury in mycophenolate mofetil-related colitis.

Authors:  A I Al-Absi; C R Cooke; B M Wall; P Sylvestre; M K Ismail; M Mya
Journal:  Transplant Proc       Date:  2010-11       Impact factor: 1.066

Review 4.  Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Authors:  M Behrend
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 5.  Cytomegalovirus colitis during mycophenolate mofetil therapy for Wegener's granulomatosis.

Authors:  A Woywodt; M Choi; W Schneider; R Kettritz; U Göbel
Journal:  Am J Nephrol       Date:  2000 Nov-Dec       Impact factor: 3.754

6.  Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease.

Authors:  T Spieker; H Herbst
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?

Authors:  E Wieland; M Shipkova; U Schellhaas; E Schütz; P D Niedmann; V W Armstrong; M Oellerich
Journal:  Clin Biochem       Date:  2000-03       Impact factor: 3.281

8.  Epstein-barr virus-related diarrhea or exacerbation of inflammatory bowel disease: diagnostic dilemma.

Authors:  Ido Weinberg; Tzahi Neuman; Maya Margalit; Fadeela Ayman; Dana G Wolf; Arie Ben-Yehuda
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

9.  Pharmacology of immunosuppressive drugs.

Authors:  A J Olyaei; A M de Mattos; W M Bennett
Journal:  Drugs Today (Barc)       Date:  1998-05       Impact factor: 2.245

10.  Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern.

Authors:  John C Papadimitriou; Charles B Cangro; Alexander Lustberg; Amr Khaled; Joseph Nogueira; Ann Wiland; Emilio Ramos; David K Klassen; Cinthia B Drachenberg
Journal:  Int J Surg Pathol       Date:  2003-10       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.